Advance Syntex Limited Fundamental Analysis (BSE: ASYL.BO)
Advance Syntex Limited Fundamental Analysis (BSE: ASYL.BO)
Advance Syntex Limited (BSE: ASYL.BO) shows weak financial fundamentals with a PE ratio of -0.31, profit margin of 0.00%, and ROE of 1.42%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze ASYL.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakASYL.BO struggles to generate sufficient returns from assets.
Valuation Score
ExcellentASYL.BO trades at attractive valuation levels.
Growth Score
WeakASYL.BO faces weak or negative growth trends.
Financial Health Score
ModerateASYL.BO shows balanced financial health with some risks.
Profitability Score
WeakASYL.BO struggles to sustain strong margins.
Key Financial Metrics
Is ASYL.BO Expensive or Cheap?
P/E Ratio
ASYL.BO trades at -0.31 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ASYL.BO's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Advance Syntex Limited at -0.54 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.81 times EBITDA. This is generally considered low.
How Well Does ASYL.BO Make Money?
Net Profit Margin
For every $100 in sales, Advance Syntex Limited keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.42 in profit for every $100 of shareholder equity.
ROA
Advance Syntex Limited generates $-1.45 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
ASYL.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.31
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.001
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.54
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.84
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.54
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
1.42
vs 25 benchmark
ROA
Return on assets percentage
-1.45
vs 25 benchmark
ROCE
Return on capital employed
3.67
vs 25 benchmark
How ASYL.BO Stacks Against Its Sector Peers
| Metric | ASYL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.31 | 28.27 | Better (Cheaper) |
| ROE | 141.51% | 1119.00% | Weak |
| Net Margin | 0.00% | -20989.00% (disorted) | Weak |
| Debt/Equity | -1.84 | 0.80 | Strong (Low Leverage) |
| Current Ratio | 0.54 | 21.75 | Weak Liquidity |
| ROA | -145.02% | -1330684.00% (disorted) | Weak |
ASYL.BO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Advance Syntex Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure